Mouse Models For Studying Factors That Control Inflammation in AMD

Noriko Esumi, MD, PhD
Johns Hopkins University (Baltimore, MD)
Year Awarded:
2012
Grant Duration:
July 1, 2012 to June 30, 2015
Disease:
Macular Degeneration
Award Amount:
$100,000
Grant Reference ID:
M2012102
Award Type:
Standard
Award Region:
US Northeastern

Mouse Models For Studying The Role Of Inflammation in AMD

Summary

Age-related macular degeneration (AMD) is thought to result from abnormalities of the retinal pigment epithelium (RPE), the cell layer that nourishes and detoxifies the retina. Chronic inflammation is a major underlying condition of aging, taking its toll on many organs. Various environmental stimuli, such as oxidative stress and inflammatory molecules, converge upon a critical master regulator of inflammation. However, the specific roles of chronic inflammation and its master-regulator protein in the RPE and AMD are still unknown. Therefore, Dr. Noriko Esumi and colleagues propose to engineer two new types of mice to address the biological role of this inflammation master regulator and its key partner in the RPE, and to ultimately evaluate whether targeting these inflammation proteins is a possible strategy for AMD treatment or prevention.

Details

Chronic inflammation is thought to be an important underlying condition of aging and many age-related diseases, including AMD; but it is not known specifically how chronic inflammation ages the RPE, essentially tipping the scales toward developing AMD. Dr. Noriko Esumi and colleagues will provide two new types of engineered mice to study the involvement of inflammation in aging of the RPE and how this might lead to AMD. The first aim of the study involves making a mouse in which the master regulator of inflammation can be blocked at desired times for a desired duration in the RPE by giving the mouse a drug. The second aim of the study involves making another mouse in which the second protein that controls the master regulator of inflammation can be expressed at higher levels at desired times for a desired duration in the RPE. For both types of mice, Esumi's team will check whether the introduced genes are expressed and activated by the drug. Then, this team will begin to test whether the changes in gene expression can protect the RPE cells from oxidative stress.

Most previous studies to understand the role of inflammation have been conducted using cultured RPE cells for short-term observation, not with live animals for long-term analyses. Therefore, this project is unique in three specific ways: 1) it provides for the first time tools for studying the role of inflammation and its critical regulators in the RPE cells of live animals; 2) the gene of interest in the mice can be induced at desired times for a desired duration by giving a drug, and therefore can be reversed; and 3) one of the regulators is clearly a new player in studies of RPE and AMD. Depending on the results of this study, the master regulator and its modulators could be great candidates for new drugs to treat or prevent AMD.